The Next-generation sequencing market is expected to grow from USD 8.26 billion in 2019 to USD 38.48 billion by 2026 at a CAGR of 22.15% from 2020 to 2026.
Next-generation sequencing is a DNA sequencing technology. The procedure of DNA sequencing, which chooses the exact order of nucleotides inside a DNA molecule, is known as Next-generation sequencing. Next-generation sequencing is high throughput sequencing. Using next-generation sequencer, the process products a million DNA molecules and RNA sequences by allowing rapid nucleotide sequencing. The all-in-one approach presented by next-generation sequencing assays minimizes the time essential to identify the cause of a condition, compared to sequential molecular tests, contributing to the enhanced health outcome. In the present situation, liquid biopsies for early discovery and monitoring of cancer, and diversification of the reproductive health market exhibits a substantial capacity for the technology in the near future.
View Complete Report: @ https://marketreportslibrary.com/report/he0464/next-generation-sequencing-market
The global Next-generation Sequencing market has been segmented as below:
By Application
Drug Discovery
Agriculture & Animal Research
Other Applications
Diagnostics
Reproductive Health Diagnostics
Infectious Disease Diagnostics
Cancer Diagnostics
Other Diagnostic Applications
By End-User
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Academic Institutes & Research Centers
Other End Users
By Technology
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Sequencing by Synthesis
Other Sequencing Technologies
By Product & Services
NGS consumables
Services for NGS Platforms
Bioinformatics
Data Analysis Software & Workbenches
Data Analysis Services
Storage, Management, and Cloud Computing Solutions
Sequencing Services
Presequencing Products & Services
Quality Control
Library Preparation & Target Enrichment
NGS Platforms
Oxford Nanopore Technologies
Pacific Biosciences
PacBio RS II Systems
Sequel Systems
Thermo Fisher Scientific
Ion PGM Systems
Ion Proton Systems
Ion GeneStudio S5 Systems
Illumina
NextSeq Systems
MiniSeq Systems
NovaSeq Systems
iSeq 100 Systems
HiSeq Systems
HiSeq X Ten & HiSeq X Five
MiSeq Systems
Others
By Region
North America
Europe
Asia-Pacific
Rest of the World
Competitive Rivalry
Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
Request a Sample of this Report: @ https://marketreportslibrary.com/request/sample/he0464/next-generation-sequencing-market
Explore other reports from ”Healthcare” sector @ https://marketreportslibrary.com/category/healthcare

Contact Us:
SRR residency Mig-59,
7th phase Kphb colony
Near prathibha school
Hyderabad, 500072
[email protected]